Leah B Sansbury

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low-fat eating pattern on adenoma recurrence
    Leah B Sansbury
    Division of Cancer Control and Population Sciences, 6130 Executive Boulevard, Room 5106, Mail Stop Code 7324, Bethesda, MD 20892, USA
    Am J Epidemiol 170:576-84. 2009
  2. ncbi Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites
    Leah B Sansbury
    Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8325, USA
    Am J Epidemiol 162:548-58. 2005
  3. ncbi COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States)
    Leah B Sansbury
    Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892 8325, USA
    Cancer Causes Control 17:257-66. 2006
  4. ncbi Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial
    Leah B Sansbury
    Center for Cancer Research, National Cancer Institute, NIH, Department of Health and Human Services, Suite 702, 6116 Executive Boulevard, MSC 8235, Bethesda, MD 20892 8325, USA
    Cancer Epidemiol Biomarkers Prev 15:494-501. 2006
  5. ncbi Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial
    Gerd Bobe
    Center for Cancer Research, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland, USA
    Cancer Prev Res (Phila) 3:764-75. 2010
  6. ncbi Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial
    Gerd Bobe
    Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute NCI, National Institutes of Health NIH, Department of Health and Human Services DHHS, Frederick, MD, USA
    Int J Cancer 130:1649-59. 2012
  7. ncbi Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA
    Clin Gastroenterol Hepatol 7:192-7. 2009
  8. ncbi Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial
    Gerd Bobe
    Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute NCI, NIH, Department of Health and Human Services DHHS, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 19:1441-52. 2010
  9. ncbi Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?
    Gerd Bobe
    Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Eur J Cancer Prev 20:86-95. 2011
  10. ncbi Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Biometry Research Group, Divisionof Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann Intern Med 148:419-26. 2008

Detail Information

Publications16

  1. ncbi The effect of strict adherence to a high-fiber, high-fruit and -vegetable, and low-fat eating pattern on adenoma recurrence
    Leah B Sansbury
    Division of Cancer Control and Population Sciences, 6130 Executive Boulevard, Room 5106, Mail Stop Code 7324, Bethesda, MD 20892, USA
    Am J Epidemiol 170:576-84. 2009
    ..65, 95% confidence interval: 0.47, 0.92). Findings suggest that high compliance with a low-fat, high-fiber diet is associated with reduced risk of adenoma recurrence...
  2. ncbi Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites
    Leah B Sansbury
    Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8325, USA
    Am J Epidemiol 162:548-58. 2005
    ..These results add new knowledge suggesting that the protective effect of NSAIDs against colon cancer is similar among African Americans and Whites...
  3. ncbi COX-2 polymorphism, use of nonsteroidal anti-inflammatory drugs, and risk of colon cancer in African Americans (United States)
    Leah B Sansbury
    Cancer Prevention Fellowship Program, Division of Cancer Prevention, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892 8325, USA
    Cancer Causes Control 17:257-66. 2006
    ..We explored the association between the COX-2 Val511Ala SNP and risk of colon cancer among 240 African American cases and 326 African American controls in a population-based, case-control study in North Carolina...
  4. ncbi Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial
    Leah B Sansbury
    Center for Cancer Research, National Cancer Institute, NIH, Department of Health and Human Services, Suite 702, 6116 Executive Boulevard, MSC 8235, Bethesda, MD 20892 8325, USA
    Cancer Epidemiol Biomarkers Prev 15:494-501. 2006
    ..Furthermore, common variants in cytokine genes may modify the anti-inflammatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) in the prevention of colorectal cancer...
  5. ncbi Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial
    Gerd Bobe
    Center for Cancer Research, National Cancer Institute, NIH, Department of Health and Human Services, Bethesda, Maryland, USA
    Cancer Prev Res (Phila) 3:764-75. 2010
    ..Our results suggest that serum IL-6 may serve as a risk indicator and as a response indicator to dietary flavonols for colorectal cancer prevention...
  6. ncbi Dietary lignan and proanthocyanidin consumption and colorectal adenoma recurrence in the Polyp Prevention Trial
    Gerd Bobe
    Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute NCI, National Institutes of Health NIH, Department of Health and Human Services DHHS, Frederick, MD, USA
    Int J Cancer 130:1649-59. 2012
    ..04). To conclude, dietary lignan and proanthocyanidin consumption were not generally related to colorectal adenoma recurrence; however, high lignan intake may increase the risk of adenoma recurrence in women...
  7. ncbi Hyperplastic polyps and the risk of adenoma recurrence in the polyp prevention trial
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, Bethesda, Maryland 20892, USA
    Clin Gastroenterol Hepatol 7:192-7. 2009
    ..Prospective information on the risk of adenoma recurrence associated with hyperplastic polyps is limited. We sought to investigate whether the coexistence of hyperplastic polyps with adenomas increases the risk of adenoma recurrence...
  8. ncbi Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial
    Gerd Bobe
    Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute NCI, NIH, Department of Health and Human Services DHHS, Bethesda, Maryland, USA
    Cancer Epidemiol Biomarkers Prev 19:1441-52. 2010
    ..Serum adiponectin, leptin, C-peptide, and homocysteine are indicators for obesity, hyperinsulinemia, and chronic inflammation, which have all been associated with colorectal cancer...
  9. ncbi Do interleukin polymorphisms play a role in the prevention of colorectal adenoma recurrence by dietary flavonols?
    Gerd Bobe
    Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, USA
    Eur J Cancer Prev 20:86-95. 2011
    ..In conclusion, our results suggest that IL SNPs, in combination with a flavonol-rich diet or decreased serum IL, may lower the risk of adenoma recurrence...
  10. ncbi Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years
    Adeyinka O Laiyemo
    Cancer Prevention Fellowship Program, Biometry Research Group, Divisionof Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann Intern Med 148:419-26. 2008
    ..Lack of confidence in postpolypectomy surveillance guidelines may be a factor in the observed low adherence rates among providers...
  11. ncbi Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial
    Gwen Murphy
    Cancer Prevention Fellowship Program, Office of Preventive Oncology, Bethesda, MD, USA
    Cancer Causes Control 19:751-8. 2008
    ..A C/T transition at position 677 in the gene encoding methlylenetetrahydrofolate reductase (MTHFR C677T) has been reported to interact with folate intake to modulate colorectal adenoma recurrence or cancer risk...
  12. ncbi Dietary flavonoids and colorectal adenoma recurrence in the Polyp Prevention Trial
    Gerd Bobe
    Laboratory of Cancer Prevention, National Cancer Institute Frederick, Room 110, Building 576, Frederick, MD 21702 1201, USA
    Cancer Epidemiol Biomarkers Prev 17:1344-53. 2008
    ..Our data suggest that a flavonol-rich diet may decrease the risk of advanced adenoma recurrence...
  13. ncbi Nutrition and cancer prevention: targets, strategies, and the importance of early life interventions
    Stephen D Hursting
    Laboratory of Biosystems and Cancer, Center for Cancer Research, Bethesda, MD, USA
    Nestle Nutr Workshop Ser Pediatr Program 57:153-202. 2006
  14. ncbi Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation
    Andrew N Freedman
    National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7393, USA
    J Natl Cancer Inst 102:1698-705. 2010
    ....
  15. ncbi Physicians' use of nonphysician healthcare providers for colorectal cancer screening
    Leah B Sansbury
    Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, Maryland 20892-7344, USA
    Am J Prev Med 25:179-86. 2003
    ..However, physician beliefs about the ability of nurse practitioners and physician assistants to perform flexible sigmoidoscopy are a potential barrier to increasing the involvement of nonphysician providers in CRC screening delivery...
  16. ncbi Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm)
    Karyn B Stitzenberg
    Division of Surgical Oncology, Department of Surgery, 3010 Old Clinic Building, CB#7213, University of North Carolina, Chapel Hill, NC 27599-7213, USA
    Ann Surg Oncol 11:900-6. 2004
    ....